Sažetak
Purpose: This study aimed to investigate the causal relationship between plasma lipid levels—total cholesterol (TC), triglycerides (TGs), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C)—and the risk of squamous cervical cancer (SCC) using Mendelian Randomization (MR).
Materials and Method: Genome-wide association study (GWAS) data for plasma lipid traits were obtained from the Global Lipids Genetics Consortium (GLGC), and SCC outcome data were sourced from the FinnGen consortium. The primary analysis was conducted using the inverse variance weighted (IVW) method, supported by MR-Egger regression, weighted median, and weighted mode approaches. Sensitivity analyses were performed to assess the robustness of the results, and the Steiger test was used to evaluate the directionality of the associations.
Results: The IVW analysis revealed that higher plasma levels of TC (OR: 1.777; 95% CI: 1.118–2.825; p = 0.015) and LDL-C (OR: 1.674; 95% CI: 1.013–2.767; p = 0.044) were associated with an increased risk of SCC. No significant associations were found between TGs (OR: 0.644; 95% CI: 0.343–1.212; p = 0.173) or HDL-C (OR: 1.050; 95% CI: 0.616–1.790; p = 0.857) and SCC.
Conclusions: This study provides evidence of a causal relationship between elevated plasma TC and LDL-C levels and a higher risk of SCC, highlighting a novel aspect of SCC etiology. These findings may inform further functional and clinical research in the progression of SCC.
Ključne reči
Array
Array
Array
Array
Reference
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.